Monthly archives for August, 2023
| Ajanta Pharma is a focused player in branded generics. Buy for target price Rs 1950 (26% upside) | |
| Company: | Ajanta Pharma |
| Brokerage: | ICICI-Direct |
| Date of report: | August 28, 2023 |
| Type of Report: | Result Update |
| Recommendation: | Buy |
| Upside Potential: | 26% |
| Summary: | Ajanta Pharma is a focused player in branded generics, which constitutes ~72% of overall sales, spread across geographies including India. |
| Full Report: | Click here to view full post with link to download pdf file |
| Tags: | Ajanta Pharma, ICICI-Direct |
| FinNifty Bear Spread Strategy with Risk Reward Ratio of 1:1.62 | |
| Company: | Finnifty |
| Brokerage: | HDFC Sec |
| Date of report: | August 3, 2023 |
| Type of Report: | Techno-Funda |
| Recommendation: | Sell |
| Upside Potential: | 3% |
| Summary: | Technically, FinNifty has broken down from last three days of consolidation and formed a bear candle |
| Full Report: | Click here to view full post with link to download pdf file |
| Tags: | Finnifty, HDFC Sec |
| HDFC Bank is a conviction buy for target price of Rs 2050 (26% upside): ICICI Direct | |
| Company: | HDFC Bank |
| Brokerage: | ICICI-Direct |
| Date of report: | August 4, 2023 |
| Type of Report: | Result Update |
| Recommendation: | Buy |
| Upside Potential: | 26% |
| Summary: | Valuing the merged entity on SOTP basis assigning 2.5x FY25E ABV for lending business (merged basis) and ₹ 144 for subsidiaries arriving at a target of ₹ 2050 per share. Maintain BUY rating on the stock |
| Full Report: | Click here to view full post with link to download pdf file |
| Tags: | HDFC Bank, ICICI-Direct |
| Nifty has entered bearish territory – Elliot wave perspective by HDFC Sec | |
| Company: | Model Portfolio, Nifty |
| Brokerage: | HDFC Sec |
| Date of report: | August 4, 2023 |
| Type of Report: | Techno-Funda |
| Recommendation: | Sell |
| Upside Potential: | 5.77% |
| Summary: | Nifty Last Close – 19527 “Entered into bearish territory” |
| Full Report: | Click here to view full post with link to download pdf file |
| Tags: | Elliot wave, HDFC Sec, NIFTY |
| Birlasoft has good growth prospects. Buy for target price of Rs 530 (23% upside): HDFC Sec | |
| Company: | Birla Soft |
| Brokerage: | HDFC Sec |
| Date of report: | August 4, 2023 |
| Type of Report: | Initiating Coverage |
| Recommendation: | Buy |
| Upside Potential: | 23% |
| Summary: | Based on our mid-tier IT assessment framework, client cohort analysis and industry checks, we are positive about BSOFT’s growth prospects. We initiate on BSOFT with a BUY recommendation and a TP of INR 530, based on 21x Jun-25E with 20% EPS CAGR over FY23-26E |
| Full Report: | Click here to view full post with link to download pdf file |
| Tags: | Birlasoft India, HDFC Sec |